NPR

Cancer Drug That Might Slow Parkinson's, Alzheimer's Headed For Bigger Tests

In a preliminary study, the cancer drug nilotinib seemed to help patients with Parkinson's and dementia. Now two larger and more rigorous studies of the drug are under way.
A colored magnetic resonance imaging (MRI) scans of the brain of a 76-year-old patient with dementia shows the brain has atrophied and the dark brown fluid-filled spaces have become enlarged.

Scientists are hoping that a single drug can treat two devastating brain diseases: Parkinson's and Alzheimer's.

The drug is nilotinib, which is approved to treat a form of leukemia.

In late 2015, researchers at Georgetown University Medical Center that small doses of the drug appeared to help a handful of people with Parkinson's disease and a related form of dementia. They'd tried the unlikely treatment because they knew nilotinib triggered cells to get

You’re reading a preview, subscribe to read more.

More from NPR

NPR2 min read
Mystik Dan Wins The Kentucky Derby By A Nose
In a close finish, Mystik Dan won the Kentucky Derby by a horse's nostril over Sierra Leone. Contenders waited with bated breath in the seconds before the official decision was made. The thoroughbred had entered the race with 18-1 odds — a longshot c
NPR4 min read
'Zillow Gone Wild' Brings Wacky Real Estate Listings To HGTV
Zillow Gone Wild started in 2020 as an Instagram account devoted to eccentric property listings. The show focuses on homes that defy everyday expectations in some way.
NPR4 min read
Cicadas Are Back On The Menu. One Chef Shares His Dish Ideas — And An Easy Recipe
The cicadas are coming! And so are some new flavor profiles. This spring, the bugs of two broods, the 13-year Brood XIX and the 17-year Brood XIII, will crawl from the ground simultaneously across the eastern and southern parts of the United States.

Related Books & Audiobooks